Tuesday, November 13, 2018
Print Current Session:
|
|
Tuesday
SESSION 5:
NEW DEVELOPMENTS IN EVAR AND AAA
|
|
SESSION 5 SCHEDULE | |
1:00 PM - 1:05 PM | Decades Of AAA RCTs And Registries: What Do They Tell Us; What Do They Tell Us That Is Wrong; And What Don’t They Tell Us |
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | Maintenance Of Durability Of All Types Of Endovascular Repair By A Simple, Safe And Patient Friendly Method Recommended To The NICE Aortic Guidelines |
Presenter(s):Roger M. Greenhalgh, MD Location: Grand Ballroom West, 3rd Floor |
|
1:12 PM - 1:17 PM | Late Results Of The DREAM And OVER RCTs Did Not Show The Same Late Survival Benefit For OR As EVAR 1: Possible Reasons And Should EVAR Be The Treatment Of Choice For All Anatomically Suitable AAA Patients |
Presenter(s):Jan D. Blankensteijn, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | EVAR Results Have Improved Since 2004: EVAR Should Be The Treatment Of Choice For All AAA Patients With Suitable Anatomy |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | Drugs To Slow AAA Growth: Will Metformin Do It And How Is Metformin Related To Decreased AAA Incidence In Diabetes |
Presenter(s):Ronald L. Dalman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | High LDL Cholesterol (LDL-C) And Triglycerides Can Promote AAA Growth: Could Statins And PCSK-9 Inhibitors Slow It |
Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | Different Patterns Of AAA Neck Dilatation After OR And EVAR With Various Self-Expanding Or Polymer Sealing Devices: Why It Matters And Which Is Best With Short Sealing Zones |
Presenter(s):David J. Minion, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:42 PM - 1:48 PM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / Keith D. Calligaro, MD | |
1:48 PM - 1:53 PM | AAA Rupture After EVAR: Etiology, Best Treatment And Outcomes |
Presenter(s):Eric Ducasse, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:54 PM - 1:59 PM | Value Of 3D Contrast Enhanced Duplex Ultrasound (CEDU) In Evaluating AAAs: It Can Quantitate Thrombus Volume As A Biomarker And Follow AAA Volume To Monitor Growth More Accurately |
Presenter(s):Henrik Sillesen, MD, DMSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:05 PM | DEBATE: Patient Compliance After EVAR: Can Poor Compliance Be Predicted: Is It Bad And Should Non-Compliant Patients Have Open Surgery |
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:06 PM - 2:11 PM | DEBATE: Non-Compliance After EVAR Is No Big Deal: It Does Not Increase Aneurysm Related Or All Cause Mortality |
Presenter(s):Pete Holt, MD, PhD / Matthew Joe Grima, MD, MRCSEd, MSc, ChM / Ian Loftus, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | Update On Predicting AAA Growth Rates And Rupture Risk From Smooth Muscle Behavior (Grown From Skin Biopsies): This Correlates With AAA Wall Strength |
Presenter(s):Kak Khee Yeung, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | Intrasac Thrombus In AAAs May Lower Wall Strength And Increases Rupture Risk: What Is The Mechanism |
Presenter(s):Gregory L. Moneta, MD / Gregory J. Landry, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:24 PM - 2:29 PM | How Is MR Evaluated Mural Thrombus In AAAs Associated With Predicting Their Growth Rates |
Presenter(s):Jes S. Lindholt, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:30 PM - 2:36 PM | Panel Discussion |
END OF SESSION 5 | |
previous | next |